Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in Relapsed/Refractory Mantle Cell Lymphoma
NCT01739309Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of abemaciclib in mantle cell lymphoma (MCL), sponsored by Eli Lilly and Company. Started Mar 2013; status: completed.
02
Drugs
abemaciclib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01739309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01739309.